Illumina continues to forge partnerships with diagnostic developers overseas as it eyes approximately 50 population sequencing projects around the world.
In Genome Research this week: collection of circular RNAs from breast cancers, chromosome-scale genome assembly for the axolotl, and more.
The new regulatory approvals add to previous approvals in Singapore, expanding the firm's reach in the Association of Southeast Asian Nations region.
The researchers presented new reagents and software for de novo peptide sequencing, an emerging technology with potential in proteomics and biopharma.
The Associated Press reports that Nobel laureate Craig Mello was informed about He Jiankui's efforts to edit human embryos.
AmoyDx's kit is designed to detect hotspot mutations/fusions in nine genes to help guide treatment decisions for non-small cell lung cancer patients.
Japanese researchers developed a catalog of HLA alleles that they used to perform a phenome-wide association study of the MHC and about a hundred phenotypes.
In PLOS this week: statistical approach for integrating eQTL and GWAS data, microRNA signature distinguishes malignant and benign salivary gland tumors, and more.
The effort, led by BGI-Shenzen researchers, could help further plant sequencing studies and inform upcoming large-scale plant sequencing plans.
The New York Times reports on international efforts to oversee and regulate gene-editing work.
The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.
Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.
One gene regulates hundreds of others to influence facial development, according to New Scientist.
In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.